Purchase Order HHSN261201500355P

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. on August 16, 2016, with a ceiling value of $3,657.02 and an ultimate completion date of September 16, 2017. The order is firm fixed price with no set-aside. Work is performed in Bethesda, Maryland. Bio-Rad supplied laboratory equipment and instrumentation to support the Institute's research operations.</p>

<p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. valued at $7,672.44 on August 9, 2016, with final completion scheduled for August 14, 2017. Work is performed at Bio-Rad's facility in Bethesda, Maryland. The order covers laboratory equipment, reagents, or consumables supplied on a firm fixed-price basis. No small business set-aside was applied.</p>

The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. valued at $16,773.68 on November 3, 2020, with an ultimate completion date of November 14, 2021. The order, priced on a firm fixed-price basis, represents a maintenance agreement to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. Performance occurs in Rodeo, California. No...

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $1,284.75 on November 13, 2015, with completion on November 14, 2016. No set-aside was used. Performance is located in Bethesda, Maryland. The order is firm fixed price. The specific equipment or reagent items procured are not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $6,282.00 on February 3, 2016, with completion scheduled for February 9, 2017. Work is performed at Bethesda, Maryland. The order covers laboratory equipment and instrumentation on a firm fixed-price basis. No small business set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $29,040 on July 21, 2016, for Bio-Rad ChemiDoc Touch imaging equipment. No set-aside was used. Performance is at Bio-Rad's facility in Rodeo, California. The order carries a firm fixed-price structure and an ultimate completion date of January 20, 2021. The award represents a de-obligation of expiring FY2016 funds for laboratory instrumentation supporting biomedical research operations.</p>

The National Cancer Institute awarded a $24,995 firm fixed-price Blanket Purchase Agreement (BPA) call to Bio-Rad Laboratories, Inc.'s Life Science Group Division on September 14, 2016, for laboratory equipment and supplies. The contract was completed by October 7, 2016, with performance at the NCI facility in Bethesda, Maryland. This award was not designated as a small business set-aside, consistent with Bio-Rad's positioning as an established large federal contractor. The call was placed...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $23,340 purchase order to Bio-Rad Laboratories, Inc.'s Diagnostics Division for maintenance services. As the prime contractor, Bio-Rad Laboratories will perform the maintenance work itself at its facility in Hercules, California under a firm fixed price contract that runs from January 2024 through January 2025. No subcontractors or set-aside designations were identified. The award...

This is a one-year, firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division for digital PCR maintenance services. The $23,808.00 contract has a completion date of September 28, 2025. No set-aside designation was used. This award is associated with Bio-Rad's $1 billion Blanket Purchase Agreement with the National Institutes of Health Office of Logistics and Acquisition Operations, which facilitates the procurement of...

Bio-Rad Laboratories, Inc. was awarded a $24,995 firm fixed-price BPA call by the National Cancer Institute on June 26, 2017, for laboratory equipment with an ultimate completion date of July 31, 2017. The contract was performed in Bethesda, Maryland and did not utilize a small business set-aside. Bio-Rad, a global leader in life science research and clinical diagnostics headquartered in Hercules, California, supplied specialized laboratory instrumentation through its Life Science Group...